HYDERABAD: As a landmark development for cancer patients, the Global hospitals group announced on Wednesday the launch of BGS Global Cancer Institute at Bengaluru. Considered as one of the world’s most advanced radiation therapy machine, the TrueBeam Stx is an advanced radiation therapy machine engineered to perform the most sophisticated radiation therapy and radio-surgery procedures with pinpoint accuracy and ultra-fine precision. It works by choreographing highly sophisticated systems - imaging, beam delivery and motion management -making it possible to deliver treatments quickly while monitoring and compensating for tumor motion. It will enable faster, accurate tumor targeting in the treatment of challenging cancers throughout the body, including those in the brain, pancreas and liver. Already installed and operational, radiation oncologists at BGS Global Hospitals have begun routinely performing complex procedures with seemingly amazing precision and patient comfort.
In India while there are some centers which are equipped with normal TrueBeam, the BGS Global Hospitals is introducing TrueBeam STx for the first time in Asia Pacific.
Speaking on the occasion, Dr K Ravindranath, chairman and managing director, Global hospitals group said, “We have been continuously investing on the most advanced technologies. I am personally very delighted to bring to the people Asia Pacific’s first TrueBeam STx. Since, inception, we have been routinely performing medical and surgical procedures to treat a variety of cancers. The addition of TrueBeam STx will now help us in bringing the cancer patients requiring radiation therapy, the best radiation technology ever. We will soon be commissioning Gamma Camera and Brachy Therapy machines too, while PET CT is already commissioned.”
Mr David James, director of Surgical Sciences at Varian Medical Systems, Germany, makers of TrueBeam STX, said, “The high precision, accuracy and visibility of Trubeam STx provide the cancer professionals with the tools they need to eliminate even complex tumors. With this technology, they will have the ability to expand their practice by treating in new and innovative ways. They now can spare more surrounding critical structures and deliver more ablative treatments with leading-edge delivery of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). ”